Program Goals
21
-
Upload
ria-pickett -
Category
Documents
-
view
24 -
download
0
description
Program Goals. Gastric and Esophageal Cancer in the United States, 2013. REGARD Ramucirumab Monotherapy in Second-line Gastric/GEJ Cancer, Phase 3 Trial. REGARD Efficacy Results. RAINBOW Ramucirumab in Second-line Gastric/GEJ Cancer, Phase 3 Trial. - PowerPoint PPT Presentation